Carnitine in the treatment of geriatric depression
CA 2469925 A1 · Owner: Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. · Inventors: Gershon, Samuel; Pettegrew, Jay W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to use of a carnitine selected from L-carnitine or alkanoyl L-carnitine, preferably acetyl L-carnitine or of a pharmaceutically , acceptable salt thereof for the preparation of a medicament useful for treating depression in a subject, particularly geriatric subjects. The advantage of the invention stands in the efficacy of the carnitine and the lack of important side effects typical of well-known antidepressants.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 23, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 23, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 23, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.